Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Atopix Therapeutics Ltd.

Division of Chiesi Farmaceutici SPA
www.atopixtherapeutics.com

Latest From Atopix Therapeutics Ltd.

Novartis Progressing Trials For Oral Asthma Therapy In India

Novartis is advancing studies with its experimental asthma therapy fevipiprant in India, amid significant expectations around its possible impact on market dynamics including aspects such as the potentially shared patient pool with certain biologics.

Research & Development Clinical Trials

Confidence High As AstraZeneca Adds Asia To Benralizumab Territories

In another vote of confidence in one of its newer respiratory assets, AstraZeneca is extending to Asia its already broad rights to benralizumab, adding to a deal it already has with Kyowa Hakko Kirin for Japan.

Asia Pacific Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Chiesi Farmaceutici SPA
  • Senior Management
  • Mick Hunter, PhD, CSO
  • Contact Info
  • Atopix Therapeutics Ltd.
    Phone: 1235 841522
    Innovation Centre, 99 Park Dr.
    Abingdon, OX14 4RY
    UK
UsernamePublicRestriction

Register